Objectives. Primary biliary cirrhosis (PBC) is the second most common reason for liver transplants among women in the USA. While survival rates are high, there is evidence of persistent problems post-transplant. This study aimed to identify significant contributors to quality of life (QOL) for women with PBC on waiting list (WL) and post-transplant (PT) and compare QOL in each group with US population norms.
analysis to identify the factors that were most critical for QOL and thus most in need of clinical and research attention. Fourth, comparison to national norms for QualityMetric's (2009) Short Form-36 (SF-36), a widely used measure of QOL (Ware, Kosinski, & Dewey, 2000) demonstrated the relative status of this population before and after transplant.
Very few studies of QOL in people with LD or after LT considered PBC specifically. Yet among women who had LT in the USA (OPTN, 2009) , PBC was the second most common diagnosis (after Hepatitis C). Rannard, Buck, Jones, James, and Jacoby (2004) reviewed all studies that included measurement of QOL in relation to PBC (not specific to transplant) and found only three, all of which focused primarily on the significant impact of fatigue on QOL. Gross et al. (1999) and Navasa et al. (1996) studied QOL in people with PBC PT, and Poupon, Chretien, Chazouilleres, Poupon, and Chwalow (2004) studied QOL in patients with PBC (non-transplant) compared with a control population; these studies all focused on biomedical correlates of QOL such as fatigue and disease symptoms. No research addressed either the psychological or sociological concerns or correlates of QOL in people with PBC before or after transplant.
In addition to the frequency of PBC in LT, studies showed that women with PBC have had better survival rates after LT than people with most other aetiologies (Jacob et al., 2008; Maheshwari, Yoo, & Thuluvath, 2004) . Thus, patients and their clinicians reasonably had high expectations for successful recovery following transplant. Yet even this group had ongoing concerns about organ rejection (Neuberger, 2003) and complications (Navasa et al., 1996) . Additionally, Sylvestre, Batts, Burgart, Poterucha, and Wiesner (2003) estimated that about 20-25% of patients undergoing LT for PBC would develop recurrent disease over the ensuing 10 years. Gershwin and Mackay (2008) described PBC as a slow, progressive disease of autoimmune aetiology characterized by injury of the intrahepatic bile ducts that could eventually lead to liver failure. They noted PBC's strong genetic basis, its frequent association with other autoimmune disorders, and the possibility of being triggered by environmental factors. Diagnosis was based on a combination of clinical features, in particular, fatigue and pruritus (itching; Lindor et al., 2009) .
A review of the literature on PBC concluded that its prevalence was not well established, with wide variability by country and region within a country. Gross and Odin (2008) reported that PBC was a relatively rare disease, with point prevalence estimates ranging from 11.1 to 128.0 cases per million population; they also considered it to be increasing in prevalence. Studies noted that affected individuals are usually in their fifth to seventh decades of life at the time of diagnosis, and 90% were women (Gershwin & Mackay, 2008; Parikh-Patel, Gold, Mackay, & Gershwin, 1999) . Despite evidence of an increased prevalence of PBC, the number of transplants for people with PBC declined somewhat in recent years, most likely due to an improvement in medical management of the disease symptoms (Milkiewicz, 2008) .
We used a biopsychosocial model to organize into demographic, biomedical, psychological, and sociological categories the factors identified in the literature as important correlates of QOL with chronic disease and transplantation. Efforts to move clinical research and practice towards a biopsychosocial model had been advocated for several decades (Engel, 1977; National Research Council, 2001) and were seen in a number of fields of medicine (Alonso, 2004; Coughlan, Sheehan, Bunting, Carr, & Crowe, 2004; Lindau, Laumann, Levinson, & Waite, 2003) . However, this comprehensive approach had not been applied to LT populations. Using the model allowed us to explore the broad range of potential influences on QOL in people with PBC both before and after transplant and to see which ones, when analysed together, emerged as most influential 
Demographic
Age and education were commonly used demographic characteristics that had been shown to affect QOL in other populations, with greater age generally being associated with worse QOL and greater education associated with better QOL (Desai et al., 2008; Groessl, Ganiats, & Sarkin, 2006; Sainz-Barriga et al., 2005 ). Yet Nickel et al.'s (2002) study of LD patients found no effect of age or social class on QOL. In a previous study of women with PBC, ranging from early (1 or 2) to late (3 or 4) stages (Sogolow, Lasker, & Short, 2008) , educational level was not associated with QOL, while older people in the sample had better scores on some aspects of QOL than younger people. Thus, the role of these variables was still unclear and in need of further testing.
Biomedical
Several biomedical indicators were shown to be related to QOL in people with LD: Transplant Status (De Bona et al., 2000; Gross et al., 1999; Littlefield et al., 1996; Tome et al., 2008) , Fatigue Poupon et al., 2004; Sogolow et al., 2008) , LD Symptoms (Gross et al., 1999; Saab et al., 2008) , and Medication Effects (Liu, Feurer, Dwyer, Shaffer, & Pinson, 2009; Santos et al., 2008) .
Psychological
Qualitative studies identified coping as a key theme for people waiting for transplant (Brown, Sorrell, McClaren, & Creswell, 2006; Vermeulen, Bosma, van der Bij, Koeter, & TenVergert, 2005) . However, coping had many different dimensions (Carver, Scheier, & Weintraub, 1989 ) and thus had a more complex association with QOL than most measures. Some types of coping, such as information seeking (Christensen, Ehlers, Raichle, Bertolatus, & Lawton, 2000) , were associated with better QOL following transplant, while others, such as avoidant coping (Myaskovsky et al., 2003) , were related to worse QOL. A more comprehensive analysis of coping and QOL was needed with transplant populations.
Uncertainty was also a major concern for people with chronic diseases (Bailey et al., 2009; Johnson, Zautra, & Davis, 2006; Mishel, 1999) . Mishel (1981) characterized uncertainty as a psychological state resulting from an individual's inability to form a cognitive schema -the recognition and classification of stimuli that give meaning to an event. Uncertainty in relation to illness 'occurs in situations where the decision maker cannot assign definite values to objects and events and/or is unable to accurately predict outcomes' (Bailey et al., 2009, p. 138) . Thus, uncertainty was a common concern for people both awaiting LT (Bjork & Naden, 2008) and PT (Dudley, Chaplin, Clifford, & Mutimer, 2007) .
Depression and anxiety were commonly recognized as important contributors to QOL in people with LD and in transplant patients (Blackburn, Freeston, Baker, Jones, & Newton, 2007; Goetzmann et al., 2007; Nickel et al., 2002; van Os et al., 2007) .
Sociological
Sociological variables were included less often in studies of people with LD or those who had undergone transplants. Many studies demonstrated that social support was an important factor in improved physical and mental health generally (Berkman, Glass, Brissette, & Seeman, 2000; Kawachi & Berkman, 2001 ) and in outcomes of chronic illness (Gallant, 2003; Montazeri, 2008) as well as after organ transplant (Cetingok, Hathaway, & Winsett, 2007) . Researchers also demonstrated that information about illness helped change behaviours associated with chronic illness (Ayers & Kronenfeld, 2007) , but the information must be appropriate to both patient and context (Brashers, Goldsmith, & Hsieh, 2002; Kiesler & Auerbach, 2006) , making assessment of the role of information in QOL less than straightforward. Finally, stigma was a prominent issue for people with many types of chronic illness (Grytten & Maseide, 2006; Herek, 1990; Levisohn, 2002) and was particularly a challenge for people with LD, due to the associations with substance abuse (Grundy & Beeching, 2004; Neuberger, 2007) .
In this study, we did not test the model as a whole, but rather used it as a heuristic for identifying factors expected to affect QOL in women with PBC, both while on WL and PT. Our aim was to identify and understand the relative contributions of the many QOL-related factors so that, with this evidence, strategies to improve care could be developed.
Method

Recruitment
The sample was recruited from (1) the on-line PBCers Organization, (2) the University of Pittsburgh Medical Centre, and (3) the University of Pennsylvania Health System. The project was approved by each of the medical school Institutional Review Boards as well as by Lehigh University's IRB (ORSP 05/86, 2/25/05) and by the Board of Directors of the PBCers Organization.
In previous studies of rare diseases, on-line networks were often excellent sources of participants, but they posed a risk of bias due to differences in the kinds of people (generally younger and more educated) who use the Internet and participate in support groups (Cotton & Gupta, 2004; Eysenbach & Wyatt, 2002) . The medical centres were included to expand the numbers of possible participants and to allow for examining the potential differences between on-line and medical centre samples.
Procedures
The PBCers organization, the main on-line resource for support and education of people with PBC, posted announcements about the survey on its website and on two LISTSERVs, one for all people with PBC and the other for people who were PT. Potential participants were directed to the survey at www.surveymonkey.com. The medical centres, to safeguard patient confidentiality, contacted potential participants and asked them if they would be willing to participate. If interested, individuals returned a postcard to the researchers requesting that a copy of the survey be mailed to them or that they be called for a phone interview. They were also given the option of using a link to the Survey Monkey website that was specific for their medical centre and included the consent material approved by the centre's IRB.
Measures
The Appendix describes all of the measures used and the sources where further information about psychometric properties can be found. Standardized instruments were used for Fatigue, Depression, Coping, Uncertainty, Social Support, Stigma, and QOL. All of these measures were widely used and validated in other studies. New measures were developed for those variables in the model with no appropriate standardized measures -LD Symptoms, Medication Effects, Fear/Anxiety, Information, and Social QOL.
We developed the measure LD Symptoms based on several sources: (1) the NIDDK-QA measure of the National Institute of Diabetes and Digestive and Kidney, used by transplant centres to track symptoms and other indicators of QOL in people post-LT (Kim et al., 2000) , (2) the PBC-40 instrument (Jacoby et al., 2005) , and (3) other sources describing the symptoms of PBC (e.g., Friedman, Keeffe, & Schiff, 2004; Talwalkar & Lindor, 2003) . Since there was no established standardized measure of symptoms with PBC before and after transplant, final selection of items for LD Symptoms was made using the following criteria: it fit self-report methods (i.e., we did not ask for laboratory data), and it was either common or salient enough to be known to the respondent. This measure was used in a previous study and found to be significantly associated with QOL; it was revised it slightly for the current study based on the prior results (Sogolow et al., 2008) . Similarly, we developed the list of Medication Effects from the Physician's Desk Reference descriptions of medications most commonly used by people with PBC both before and after transplant.
Based on our own prior interviews and literature (Nickel et al., 2002) , we noted that fear and anxiety about the future were commonly found both before and after transplant; therefore we asked about five sources of such fear and anxiety -not obtaining a liver when needed, infection, organ rejection, pain, and death.
We also asked, 'How helpful was the information you received from health care personnel?' while on WL. While this measure incorporates both current report for WL group and retrospective report for PT group, analyses (not reported here) showed no significant differences and thus reassured us that they could be combined.
Finally, we sought to expand the assessment of QOL to include not only physical and mental health and functioning, but also social involvement, which we called Social QOL.
Some studies suggested the difficulties posed by changes in social roles with chronic illness and the necessity of renegotiating roles before and after transplant (CrowleyMatoka, 2005; Nickel et al., 2002; Paris & White-Williams, 2005) . The SF-36 has been used as a measure of Health-Related QOL (e.g., Tome et al., 2008) , asking whether physical or emotional health interfered with 'work or other daily activities' and with 'normal social activities with family, friends, neighbours, or groups' in the past 4 weeks. We were interested in examining the domains of work, social, and family life separately and without specific reference to the impact of health. We, therefore, asked about involvement in social, family, and work life at the time of the survey.
The new measures were developed based on existing literature and face validity and were pre-tested with volunteers. The current analysis allowed us to establish their concurrent and internal consistency reliability. Scale scores resulted from summation of individual items, after recoding of some items so that higher scores were consistently indicative of a higher level of the construct being studied. The only exception was the Brief COPE, which consisted of 14 factors assessing different coping strategies; Carver indicated that each researcher who wanted to combine factors should use his or her own data (Carver, 1997 ; see the Results section, for factor analysis of the items).
Statistical analysis
Data were analysed in SPSS, version 16.0.1 (SPSS for Windows, 2007) . All variables in the model were first compared for the two groups, WL and PT. MANOVA was used to reduce the error involved in multiple t test comparisons. Missing values were imputed using the linear trend at point procedure. People who did not respond to most items in a scale were not included in analyses of those scales or in regression analyses. Response to items ranged from 93 to 100%.
Secondly, for each cohort, WL and PT, bivariate relationships between the variables in the model and QOL were analysed. Third, multiple regression analyses tested the relative importance of the 13 variables in the model in explaining QOL outcomes for the sample as a whole. In this last analysis, Transplant Status (WL vs. PT) was treated as one of the indicator variables; the dependent variables were the physical component summary (PCS) and the mental component summary (MCS) of the SF-36 and Social QOL.
Finally, SF-36 scores for each group were compared with national norms for women age 55-64, the age group that included the largest percentage of both cohorts. Since these norms were available only by age and sex category, we selected the one that most nearly matched our sample. To be sure this comparison would be valid, we compared the women in our sample who were 55-64 with those who were younger and older than that age group and found no differences in the scores on the SF-36 summary scales.
Results
Sample
A total of 100 women with PBC, 25 WL and 75 PT, completed the survey. On-line respondents were 75, 24 replied by mail, and 1 person was interviewed by phone. Participants were enrolled at one of more than 50 different transplant centres. They ranged in age from 28 to 79 (mean = 58:45); the majority (82%) of respondents were in their 50s and 60s. Time since diagnosis ranged from 1 to 31 years, with a mean of 13.5. For the PT group, the time between the surgery and the survey ranged from less than 1 year to more than 17 years, with a mean of 5.23 years.
Through the PBCers site 68 women were recruited. The organization had approximately 2,500 members at the time of the study, but not all members were eligible. Some did not have PBC (family members, health professionals, and friends participate as well), and many of those who did were at early stages of the disease. It was impossible to know how many people who fit the eligibility criteria were aware of the study, and therefore the response rate was unknown. The 32 women recruited through their medical centres represented almost one-third (31.7%) of those who were sent letters asking them to participate. Of the PBCers participants, 27.9%, compared with 18.8% of the medical centre participants, were on the WL (difference not statistically significant). When examining PT participants only, those recruited through the PBCers site were younger (mean age 57.2 years for PBCers vs. 61.8 years for those participating via medical centres; t = 22:42, p = :018). The PT participants were not significantly different on any of the other variables in the model. Therefore, participants recruited from different sources were combined for analysis.
Internal consistency reliability of measures used
See the Appendix for Cronbach's alpha for all of the measures used in this sample; all had good internal consistency reliability except Social QOL. When the two measures of Stigma were compared, the adapted Berger HIV measure had a higher Cronbach's alpha than that of Gralnek's LDQoL Stigma subscale (see Appendix), very likely due to the larger number of items in the former. The two measures were also significantly intercorrelated (r = :603, p = :000). Therefore, further analyses used only the adapted Berger scale as a measure of Stigma.
The measure of Social QOL -which combined level of involvement in family, social, and work life -had an alpha of .440. It improved considerably (␣ = :695) when work involvement was omitted. Since many participants (59 of the 93 -63.4% -who responded to this question) were not working, social and family involvement combined was used as the measure of Social QOL. Overall, the face validity combined with internal consistency reliability of the new measures gave us confidence in their usefulness in the current study.
Factor analysis of the Brief COPE with the current sample resulted in two factors that we labelled Positive Coping and Negative Coping. Positive Coping included 10 of the 14 subscales (e.g., Use of Emotional Support, Positive Reframing, Planning, and Humour), and Negative Coping was composed of the other four (e.g., Denial, Substance use, Behavioural disengagement, and Self-blame).
Comparison of WL and PT participants on factors in the model
See Table 1 , for all the measures for WL and PT separately, indicating when these were significantly different from each other. As expected, the PT group scored lower on most measures of biomedical and psychological problems and higher on the SF-36.
There were no significant differences between the groups in the demographic factors (Age and Education). Results on the biomedical factors indicated that participants who had a transplant experienced less severe Fatigue and had significantly fewer LD Symptoms (mean = 1:84 out of 8) compared with the WL group (mean = 5:08). The only item that did not differ between WL and PT groups was osteoporosis. In contrast, the total average number of conditions due to Medication Effects (mean = 7:01 for WL and 5.54 for PT, out of 17) did not differ statistically across groups; only 1 out of 13 Results on psychological factors showed that Uncertainty, Depression, and Fear/Anxiety were all significantly lower in the PT group than in the WL group. Neither Positive nor Negative Coping differed between the groups. There were no differences in the sociological variables, and all three measures of QOL -PCS, MCS, and Social QOL, were significantly higher among women who were PT.
Biopsychosocial factors and QOL: Bivariate relationships
See Table 2 , for correlations for each of the factors in the model and the QOL outcomes, for WL and PT separately. For WL, higher scores on the PCS (i.e., better physical QOL) were correlated with fewer Medication Effects, less Fatigue, and less Fear/Anxiety. Higher scores on the MCS (i.e., better mental QOL) were related to older Age, fewer Medication Effects, less Fatigue, and lower Uncertainty and Depression. Higher Social 
Multiple regression
The 13 non-QOL factors in the model (see Figure 1) were entered into stepwise linear multiple regression for the sample as a whole. The results in Table 3 showed that the most important indicators of better PCS were lower Fatigue and higher Depression. The significant positive beta coefficient for Depression found in the multiple regression was due to the collinearity between Depression and Fatigue (r = :72), and indicated that although Fatigue was a good predictor of the PCS, part of the Fatigue score was determined by the reported Depression.
For the MCS, lower Depression was the only significant indicator of better mental health. Social QOL was predicted by less Fatigue, Education, and Depression and by more Positive Coping. It is important to note that Transplant Status was not a significant factor in any of the three outcome measures when all other variables were included.
Comparisons with national norms
Both WL and PT groups reported significant deficits relative to national norms for the summary scores (See Tables 4 and 5 ).
Discussion
Differences between WL and PT Results confirmed substantial improvements with transplant, as expected, but also showed continued deficits relative to national norms. For this discussion, the model's organization of variables into five categories was used to examine how each one differs between WL and PT.
(1) Demographic. Age and Education were not different between the two groups.
The lack of age difference was valuable, as it reduced the possibility that any QOL differences between WL and PT were due to normal age-related changes. (2) Biomedical. Participants reported significantly fewer LD Symptoms PT compared with WL. Fatigue also was significantly diminished for the group as a whole, but continued to be a problem for many PT participants; 18% scored 80 or higher on the Fatigue Impact Scale (Fisk et al., 1994) indicating an average response of 'moderate problem' for every item in the scale. This was consistent with the increasing body of evidence that PBC could continue following transplant (Milkiewicz, 2008) . Importantly, PT participants reported no fewer Medication Effects than WL participants. Results highlighted the persistence and salience of physical symptoms following transplant. (Pandya, Metz, & Patten, 2005) , two-thirds (66.7%) of WL participants qualified, compared with 39.7% PT. While the comparison indicated a significant improvement, concern remained that almost 40% of PT women in this sample had high scores. van Os et al. (2007) cautioned that instruments such as the CES-D were not meant to be diagnostic for depression; they concluded that their sample of people with cholestatic LD was no more depressed than the general population. Yet, scores on the CES-D in this sample were strongly associated with the MCS measure of QOL. Further study in this area is warranted. Coping strategies did not differ between WL and PT. (4) Sociological. Social Support, Stigma, and Information given by health care providers were no different between WL and PT groups, suggesting stability in perception of social relationships over time. While the function of others in a social support network necessarily changed after transplant, the assessment of the value of those support networks remained the same. Further study of the nature of and changes in social support (Lasker, Sogolow, & Sharim, 2005 ) is needed. Stigma was more dependent on the assumption by others that LD is related to alcoholism or drug abuse (Sogolow, Lasker, Sharim, Weinrieb, & Sass, 2010 ) than on factors related to transplant. With regard to Information, 50% of the WL group and 40% of the Table 5 . QOL (SF-36) summary scales, means, standard deviations, and ranges, comparing people with PBC: Post-transplant group with US norms PT groups reported that the information they received while on WL was less than 'very helpful', suggesting some desire for improved information. (5) QOL. Results confirmed the research cited earlier on improvements in QOL following LT. This study added a new dimension, Social QOL, reflecting involvement in family and social life, and showed an improvement in that area as well.
Elements in the model in relation to QOL
All of the variables, with the exception of Positive Coping and Information, were significantly related to at least one of the three QOL measures. Thus the use of a biopsychosocial model allowed us to identify a wide variety of factors that were related to QOL. Of particular note was that Medication Effects and Fatigue, both biomedical variables, were the only ones in the model related to all three measures of QOL in both groups, WL and PT. None of the other types of variables, with the one exception of Fear/Anxiety (which references specific biomedical potentialities such as infection and rejection), was related to PCS score. It was when we examined MCS and Social QOL that demographic, psychological, and sociological variables showed significant relationships. However, demographic variables were related in ways that ran counter to expectations. For those in the WL group, older Age was associated with better MCS and higher Social QOL. This contrasts with Desai et al.'s (2008) study that found worse QOL in participants over 60; however, the sample in that study ranged in age between 12 and 76 years, a much greater range than our study, which included only adults, only 10% of whom were under 50. Also, our finding was consistent with the national norms for the MCS, which increased with Age (Ware et al., 2000) .
For the PT group, more Education was correlated with less favourable MCS. Yet Sainz- Barriga et al. (2005) found a protective effect of higher education in their Italian study. Perhaps the difference was related to the selective bias in the American transplant system for people with medical care coverage, who were on average more educated (Cohen & Martinez, 2009 ).
Most important influences on QOL
In multivariate analysis, Fatigue and Depression were the most salient factors in QOL. Positive Coping also played a significant independent role in Social QOL and MCS. It may be that the challenges of Fatigue and Depression required ongoing coping efforts, and these seemed to enable a level of engagement that was important for improved QOL. Finally, Education was negatively related to Social QOL in regression analysis. This finding requires further investigation, including attention to social class, which may interact with education and outcomes. Surprisingly, Transplant Status did not have an independent impact on QOL in multivariate analysis, despite transplantation being obviously life-saving. Perhaps Transplant Status was masking important differences within the PT group, with those who had only recently had a transplant being more similar in physical status to WL than those who had survived for years. Previous studies (De Bona et al., 2000; Desai et al., 2008; Gubby, 1998; Sainz-Barriga et al., 2005) either had not addressed or found conflicting findings with regard to the impact of time since transplant on QOL. This needs further research and would help clarify expectations for those anticipating a transplant.
We examined time since transplant in relation to QOL. While it was not related to MCS in this sample, it did correlate significantly with PCS (r = :258, p = :009) and Social QOL (r = :277, p = :005), indicating improvements over time in these aspects of QOL. To test the possibility that time since transplant would be a better measure of Transplant Status than the WL-PT distinction, we ran the multivariate analysis again using time since transplant as a continuous variable, with WL assigned a value of 0. The results did not change. We also examined SF-36 scores in the PT group to see whether it would be possible to identify a point after which QOL increased substantially in this sample. We concluded from this examination that 5 years PT appeared to be such an important turning point, with a t test for differences between those who were 5 years or less and those who were more than 5 years PT being significant for PCS (t = 22:41, p = :018), although not for MCS or Social QOL.
Comparison with national norms showed continued deficits, consistent with previous cross-sectional studies (Tome et al., 2008) . Since there were significant differences in PCS in this sample between those who were 5 years or fewer PT and those who were more than 5 years PT, we compared each group separately with national norms for SF-36. The first group was significantly worse off than national norms; those who were more than 5 years beyond transplant scored no differently from the general population for the PCS but continued to be lower on the MCS (see Table 6 ). Table 6 . QOL (SF-36) summary scales, means, standard deviations, and ranges, comparing people with PBC with US norms, 5 years or less PT and more than 5 years PT
Implications for practice
Results emphasized the impact of Fatigue, Depression, and Medication Effects for all elements of QOL, and the important role of Uncertainty, Coping, Fear/Anxiety, and Stigma for some elements of QOL. These findings confirmed the importance of taking a comprehensive biopsychosocial approach in clinical care to help people with PBC improve QOL. Several implications for practice emerged from these results.
Fatigue
The underlying disease requires ongoing medical attention. Fatigue, in particular, can be deadly; Jones et al. (2006) study of people with PBC (without transplant) revealed that those with higher levels of fatigue at initial assessment were more likely to die in the subsequent years. Persistence of fatigue, even PT, should be tracked and treated with medication management and physical therapy for strength building to counteract muscle wasting and deconditioning.
Depression
Because depression is generally treatable with medications and counselling, the impact of this persistent problem can be diminished. Primary-care clinicians can play a key role in identifying and responding to depression. The findings of potentially lifelong deficits in MCS relative to national norms, and the central role of Depression in reducing QOL, require greater attention to the debilitating effects of depression.
Medication effects
It was notable that there was no reduction PT in participants' perception of problems caused by medications, but not surprising given the new medications required for immune suppression. Efforts to reduce the harmful side-effects of medications to the extent possible can be expected, based on our findings, to improve all three dimensions of QOL -physical, mental, and social.
Uncertainty and fear/anxiety
These psychological factors were both related to aspects of QOL, reflecting the uneasy reality of life with a serious chronic disease when future developments are unknown and the meaning of symptoms unclear (Lasker, Sogolow, Olenik, Sass, & Weinrieb, 2010) . The provision of information and social support can help to alleviate some of the uncertainty and fear.
Positive coping
While unrelated to any aspect of QOL in bivariate analysis, Positive Coping emerged as a significant indicator of both MCS and Social QOL in multivariate analysis. Counselling that aims to further develop positive coping skills, such as seeking support and planning, and diminish negative coping strategies, such as self-blame and denial, may be helpful.
Stigma
Both MCS and Social QOL were diminished by the perception of being stigmatized as a result of the disease. Most frequently, concerns were over others believing they were alcoholics or drug addicts, and the source of such comments was often a health care professional .
Transplant centre teams, primary-care clinicians, psychologists, and others have ongoing roles in the care of people with PBC. Our results showed the benefits of providing satisfactory information before transplant as well as the possible advantages of helping patients deal with uncertainty and stigma. Overall, the aim would be to enable and support the self-management knowledge and skills that will enhance QOL in the long term.
Further, the results indicated that physical health and Social QOL may be expected to improve over time, but that mental health may not improve or may require greater attention. The significant variables in the regression analysis (Depression and Fatigue) explained only 24.0% of the variance in PCS, leaving open the question of what other factors might help explain variation in this score. For MCS, Depression alone explained 58.3% of the variance, indicating the great potential benefits of efforts to reduce depression. Four variables -Fatigue, Depression, Positive Coping, and Educationaccounted for 61.4% of the variance in Social QOL. The recommendations above thus can contribute to improving all elements of QOL.
Limitations
Sample size A larger sample of both WL and PT participants would have increased statistical power and made it possible to detect possible additional statistically significant results. Yet PBC is a relatively rare disease, and obtaining 100 participants during 2 years of intensive recruitment efforts allowed us to arrive at valuable results. Recruiting nationally for people on WL was particularly a challenge, as persons ill enough for WL may have been less able to participate. Still, the disparity between WL and PT sample sizes reflected the nature of the populations. At any given point in time, there were approximately 450 women with PBC waiting for transplants in the USA, whereas the cumulative number of women who had LT during the same period of time as our sample (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) was about 3,500. Even considering likely mortality in the latter group, the proportions in the current study were 25% and 75%, very likely overrepresenting WL relative to PT in the population.
Study design
This study was cross-sectional, comparing WL and PT cohorts. On the plus side, the groups were derived from the same recruitment sources and were similar in age and education. Still, other unmeasured differences between the groups may have confounded findings. It would be preferable to examine a single cohort longitudinally, particularly with respect to the ability to determine causality. Nonetheless, findings from other studies that made comparisons with healthy controls were similar to those of single cohort longitudinal studies (Gershwin & Mackay, 2008; Tome et al., 2008) . This study had the advantage of including both WL and PT comparison as well as comparison of each group with national norms.
Sample bias
Almost all participants (94%) were from within the US transplant centre system, where eligibility for placement on the WL required financial/insurance resources as well as some level of Positive Coping and availability of Social Support. Therefore, it could have been that screening for transplant reduced variation in these results. Additionally, on-line recruitment, increasingly common in the study of rare diseases, had the potential for selection bias, as it reaches people who have computer access and facility and who have chosen to be part of an on-line support network. Such people have tended to be younger and more educated (Cotton & Gupta, 2004) . The participants who responded to the PBCers announcement were on average younger than the medical centre participants, but there was no other difference between the two groups, in Education or in any of the other measures. On-line recruitment yielded a higher percentage of WL participants, an advantage in reaching a relatively small and very sick population.
Measures
Not all measures had been established in other studies as valid and reliable, but the results from this study support further development of such instruments.
Conclusions
Thanks to the progress of transplant surgery and immunosuppressants, major improvements were made in survival and in reducing the side-effects from medications. This study also emphasized important improvements in mental health and social activity PT, as women had less anxiety and uncertainty about their futures as well as less fatigue. Yet, comparisons with national norms for women of similar ages showed that those who were PT continued to fall short of the well-being of the national female population, especially with regard to mental health. The value of applying a biopsychosocial model in clinical practice (Alonso, 2004) was demonstrated by the findings that a variety of biomedical, psychological, and sociological factors contributed to QOL for women with PBC. Addressing these factors -especially Fatigue and Depression, but also Uncertainty, Stigma, Medication Effects, and Coping -would mean PBC could become a chronic illness that is increasingly well-managed throughout the life-span.
